Access Bio Inc. and two other medical companies hit back at Intrivo Diagnostics Inc.'s latest lawsuit accusing them of reneging on a deal to make COVID-19 tests, saying on Thursday that Intrivo is seeking a "windfall judgment" of $1 billion without the facts to back up its claims.
Plaintiff Intrivo Diagnostics, Inc.'s suit against defendants Access Bio, Inc., Areum Bio LLC, Ivy Pharma, Inc., and unknown individuals was removed to